Hematology clinical trials are particularly complex, as they require both imaging and a comprehensive review of clinical data, leading to demanding timeline expectations. Perceptive’s operational strength and scientific knowledge meet the challenge head-on.
Perceptive Imaging has a proven track record of delivering on tight timelines without compromising data quality, supported by our clinical events adjudication team, around-the-clock operations, and a global network of over 200 hematology readers.
With 369 hematology clinical trials supported, 69 hematology-specific regulatory approvals, and 17 breakthrough therapy designations, Perceptive brings deep expertise to every study. Our experience spans global regulatory agencies, including the EMA, FDA, and NMPA.
